资讯

Doctors classify mitral valve regurgitation into four progressive stages. Symptoms typically don’t appear until the final stages but monitoring and treatment in earlier stages may help slow ...
Mitral regurgitation (MR) and tricuspid regurgitation (TR) are two conditions involving backward leakage of blood through a heart valve when a ventricle contracts. People may experience either or ...
How does this new study fit with the two major published series on outcomes of watchful waiting in patients with asymptomatic mitral regurgitation—Rosenhek et al. (Medical University of Vienna ...
Mitral regurgitation describes when the mitral valve allows blood to flow back into a person's left atrium. Learn more about its symptoms and treatment here.
Transcatheter Mitral Valve Replacement in Atrial and Ventricular Secondary Mitral Regurgitation: Insights From the ... Up Next. Presentation NY Valves 2025. Transapical Versus Transfemoral ...
Mitral Valve Regurgitation: The valve doesn’t close completely, allowing blood to leak backward into the atrium. Mitral Valve ...
UAB Division of Cardiothoracic Surgery Assistant Professor Panayotis Vardas, M.D., was recently featured on UAB’s MedCast Podcast to discuss the causes and treatment options for degenerative valve ...
Learn everything about mitral valve regurgitation—its causes, risk factors, stages, symptoms, and treatment options—in this complete and informative guide ...
While previous trials have led to questions surrounding the potential benefits of valve interventions in mitral or tricuspid regurgitation, a pair of trials presented recently demonstrate their ...
Quick Take Video Summary from The New England Journal of Medicine — Transcatheter Valve Repair for Mitral Regurgitation. Skip to main content. The New England Journal of Medicine NEJM; ...
Many patients with moderate to severe functional mitral regurgitation remain symptomatic despite receiving guideline-recommended therapy. New research findings on transcatheter mitral-valve repair ...
NEW YORK CITY -- Mitral valve technology developers were urged to go back to the drawing board due to current-generation devices not meeting the needs of enough patients with mitral regurgitation ...